COVID-19 Funding Snapshot for Pharma Developers/Manufacturers

Views as of August 7, 2020

Cassie Guo

Adam-Nover

Pharma Developers/Manufacturers

COVID-19 pharmaceutical funding landscape

COVID-19 funding has predominantly

COVID-19 drug development

U.S. funding is spread across

government vaccine supply deals

Though funding appears

Select funding deals across

US public deals with disclosed

US public deals with disclosed

Ex-US public deals

with disclosed values

Foundation deals with disclosed

Industry deals with disclosed

COVID-19 funding deals disclaimer

Contributing authors:

Tony Stripling, Associate Consultant
Sean Saunders, Life Sciences Speciaist
Jennifer Henry, Associate Consultant
Patrick Marquet, Associate

Related Insights

Healthcare Services

COVID-19

Internet Hospital in China: Current Trends and Future Directions

August 21, 2020

Internet hospital has experienced exponential growth in China and is expected to remain growth momentum in the future In this insights, L.E.K. analyzes…

Organization & Performance

COVID-19

Working from Home after COVID

July 21, 2020

COVID-19 is shaping a ‘new normal’ in working from home (WFH) that is expected to persist in the long term. L.E.K. researched how working patterns have…

Life Sciences & Pharma

Presentations

European Disease Progression Monitor: Edition 7

May 26, 2020

The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies across the Life Sciences and…

Life Sciences & Pharma

Executive Insights

Five Essential Factors for a Successful Biopharma Product Launch

November 25, 2019

Rapid changes in the biopharma industry are making it increasingly difficult to launch new products successfully.

Life Sciences & Pharma

Executive Insights

Opportunities and Patient Insights into the China Oncology Market

January 10, 2020

China’s oncology market alone represents 37% of all lung cancer, 44% of stomach cancer and 52% of liver cancer patients globally.

Organization & Performance

Executive Insights

Back to Work? Post-COVID-19 Remote Working Approaches Reveal the Adoption of Some…

September 18, 2020

As both employers and employees are increasingly encouraged to “go back to work”, early evidence indicates a wide range of post-COVID-19 flexible and…